Effectiveness of mindfulness-based cognitive therapy in patients with anxiety disorders in secondary-care settings: A randomized controlled trial.
Study Goal
The researchers aimed to examine the effectiveness of mindfulness-based cognitive therapy (MBCT) in secondary-care settings for patients with anxiety disorders who had not remitted after pharmacotherapy.
Results Summary
The study found significant reductions in both State and Trait Anxiety subscales of the STAI for the MBCT group compared to the control group, indicating MBCT's effectiveness in treating anxiety disorders in treatment-resistant patients.
Population
Adults aged 20-75 with panic disorder/agoraphobia or social anxiety disorder (DSM-IV criteria) who had not remitted after pharmacotherapy.
Effective Dosage
Not specified
Duration
Not specified
Interactions
None mentioned
| Intervention | Direction | Endpoint | Population | Dosage | Impact | Claim # |
|---|---|---|---|---|---|---|
mindfulness-based cognitive therapy (MBCT) | decrease | STAI State Anxiety subscale | patients with anxiety disorders in secondary-care settings where the vast majority of patients are treatment-resistant to pharmacotherapy | difference, -10.1; 95% confidence interval, -16.9 to -3.2; P < 0.005 | significant differences in mean change scores | #1 |
mindfulness-based cognitive therapy (MBCT) | decrease | STAI Trait Anxiety subscale | patients with anxiety disorders in secondary-care settings where the vast majority of patients are treatment-resistant to pharmacotherapy | difference, -11.7; 95% confidence interval, -17.0 to -6.4; P < 0.001 | significant differences in mean change scores | #2 |
mindfulness-based cognitive therapy (MBCT) | neutral | - | patients with anxiety disorders in secondary-care settings where the vast majority of patients are treatment-resistant to pharmacotherapy | - | is effective | #3 |
AIM: The primary objective of this study was to examine the effectiveness of mindfulness-based cognitive therapy (MBCT) in secondary-care settings where the vast majority of the patients have already undergone pharmacotherapy but have not remitted. METHODS: Eligible participants were aged between 20 and 75 years and met the criteria for panic disorder/agoraphobia or social anxiety disorder specified in the DSM-IV. They were randomly assigned to either the MBCT group (n = 20) or the wait-list control group (n = 20). The primary outcome was the difference in mean change scores between pre- and post-intervention assessments on the State-Trait Anxiety Inventory (STAI). The outcome was analyzed using an intent-to-treat approach and a mixed-effect model repeated measurement. RESULTS: We observed significant differences in mean change scores for the STAI State Anxiety subscale (difference, -10.1; 95% confidence interval, -16.9 to -3.2; P < 0.005) and STAI Trait Anxiety subscale (difference, -11.7; 95% confidence interval, -17.0 to -6.4; P < 0.001) between the MBCT and control groups. CONCLUSION: MBCT is effective in patients with anxiety disorders in secondary-care settings where the vast majority of patients are treatment-resistant to pharmacotherapy.